Nicotine in ulcerative colitis how does it work and how can we use it?

Clinical Immunotherapeutics

Volumn 5, Issue 3, 1996, Pages 169-174

  Cohen, Russell D ^a,b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; ICOSANOID; NICOTINE;

CLINICAL ARTICLE; CLINICAL TRIAL; COLON BLOOD FLOW; COLON MUCOSA; HUMAN; IMMUNOMODULATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK; ULCERATIVE COLITIS;

EID: 0029925864     PISSN: 11727039     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03259080     Document Type: Article

References (33)

1. Harries AD. Baird A. Rhodes J. Non-smoking: a feature of ulcerative colitis. BMJ 1982: 284: 706
2. Boyko EJ. Koepsell TD. Pcrera DR. et al. Risk of uleerative colitis among former and current cigarette smokers. N Engl J Med 1987: 316: 707-10
3. Lindberg E. Tysk C. Andersson K. et al. Smoking and inflammator; bowel diseuse. A case control study. Out l')X8: 29: 352-7
4. Silverstein MD. Lashner BA. Hanauer SB. Cigarette smoking and lllcerati\e colitis: a case-control study. Mayo Clin Proc 1994:69:425-9
5. Motley RJ. Rhodes J. Ford GA. el al. 'lime relationships between cessation ot smoking and onset of ulccrative colitis. Digestion 1987; 37: 125-7
6. Rudra T. Motle\ R. Rhodes J. Does smoking improve colitis'.' Scand J Gastroenterol 1989; 24 Suppl. 170: 61-3
7. Reit' S. Kleon 1. Arher N. et al. Lack of association between smoking and inflammatory bowel disease in Jewish patients in Israel. Gastroenterology 1995; 108: 1683-7
8. Lashner BA. Hanauer SB. Silverstein MD. Testing nicotine gum for uleerative colitis patients. Experience with single-patient trials. Dig Dis Sei 1990: 35 (7): 827-32
9. Srivastava ED, Russell MAM, Feyerabend C, et al. Transdermal nicotine in active ulcerative colitis. Eur J Gastroenterol Hepatol 1991; 3: 815-8
10. Guslandi M, Tittobello A. Steroid-sparing effect of transdermal nicotine in ulcerative colitis. J Clin Gastroenterol 1994; 18 (4): .147-50
11. Pullan RD, Rhodes J, Ganesh S, et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med 1994; 330 ( 12): 811 -5
12. Thomas CAO, Rhodes J, Mani V, et al. Transdermal nicotine as maintenance therapy for ulcerative colitis. N Engl i Med 1995; 332: 988-92
13. Miller LG, Goldstein G, Murphy M, et al. Reversible alterations in immunoregulatory T cells in smoking. Analysis by monoclonal antibodies and flow cytometry. Chest 1982; 5: 527-9
14. Person M, Edwards A, Lind A, et al. Low natural killer-cell activity and immunoglobulin levels associated with smoking in human subjects. Int J Cancer 1979; 23: 603-9
15. Srivastava ED, Russell MAH, Feyerabend C, et al. Smoking, humoral immunity, and ulcerative colitis. Gut 1991; 32 (9): 1016-9
16. Cope GF, Heatley RV, Kelleher J. Smoking and colonie mucosa in ulcerative colitis. BMJ 1986; 293: 481
17. Zijlstra FJ, Srivastava ED, Rhodes M, et al. Effect of nicotine on rectal mucosa and mucosal eicosanoids. Gut 1994; 35: 247-51
18. Stenson WF. Role of eicosanoids as mediators of inflammation in inflammatory bowel disease. Scand J Gastroenterol 1990; 25(172): 13-8
19. Motley RJ, Rhodes J, Williams G, et al. Smoking, eicosanoids and ulcerative colitis. J Pharm Pharmacol 1990; 42 (4): 288-9
20. Thorton WH, Adelstern EM, Edes TE. Leukotriene B4 is measurable in serum of smokers and nonsmokers. Clin Chem 1989; 35: 459-60
21. Thompson NP, Wakefield AJ, Pounder RE. Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology 1995; 108(4): 1011-5
22. Srivastava ED, Russell MAH, Feyerabend C, et al. Effect of ulcerative colitis and smoking on rectal blood flow. Gut 1990; 31: 1021-4
23. Jenkins RT, Jones DB, Goodacre RL, et al. Reversibility of increased intestinal permeability to ''Cr-EDTA in patients with gastrointestinal inflammatory diseases. Am J Gastroenterol 1987; 82: 1159-64
24. Prytz H, Benoni C, Tagesson C. Does smoking tighten the gut? Scand J Gastroenterol 1989; 24: 1084-8
25. Chadwick VS, Phillips SF, Hofmann AF. Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). II. Application to normal and abnormal permeability states in man and animals. Gastroenterology 1977; 73: 247-51
26. Bjarnason I, O'Morain C, Levi AJ, et al. Absorption of 51chromium-labeied ethylenediaminetetraacetate in inflammatory bowel disease. Gastroenterology 1993; 85: 318-22
27. Kershbaum A, Pappajohn DJ, Bellet S, et al. Effect of smoking and nicotine on adrenocorticol secretion. JAMA 1968; 203 (4): 275-8
28. Hill P, Wynder EL. Smoking and cardiovascular disease - effect of nicotine on the serum epinephrine and corticoids. Am Heart J 1974; 87 (4): 491-6
29. Wilkins JN. Carlson HE, Van Vunakis H, et al. Nicotine from cigarette smoking increases circulating levels of corticol, growth hormone, and prolactin in male chronic smokers. Psychopharmacology 1992; 78: 305-8
30. Andersson K, Siegel R, Fuxe K, et al. Intravenous injections of nicotine induce very rapid and discrete reductions of hypothalamic catecholamine levels associated with increases of ACTH, vasopressin and prolactin secretion. Acta Physiol Scand 1983; 118:35-40
31. Brenner T, Mizrachi R, Bodoff M, et al. Evidence that central nicotinic-acetylcholine receptors are involved in the modulation of basal and stress-induced adrenocortical responses. ExpNeurol 1986; 94: 735-43
32. Pauly JR, Grün EU, Collins AC. Glucocorticoid regulation of sensitivity to nicotine. In: Lippiello PM, Collins AC, Gray JA, editors. The biology of nicotine: current research issues. New York: Raven Press, 1992: 121-37
33. Sternberg EM, Chrousos GP, Wilder RL, et al. The stress response and the regulation of inflammatory disease. Ann Intern Med 1992; 117(10): 854-66